Simplex Trading
PCRX icon

Simplex Trading’s Pacira BioSciences PCRX Stock Holding History

Simplex Trading’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.26K Buy
+56
New +$1.25K ﹤0.01% 8520
2025
Q3 		– Sell
-1,598
Closed -$39.3K – 9800
2025
Q2 		$38K Sell
1,598
-2,386
-60% -$60.1K ﹤0.01% 6190
2025
Q1 		$99K Sell
3,984
-12,608
-76% -$302K ﹤0.01% 5073
2024
Q4 		$312K Buy
+16,592
New +$291K ﹤0.01% 4028
2024
Q2 		– Sell
-2,281
Closed -$64.9K – 9558
2024
Q1 		$66K Buy
+2,281
New +$70.1K ﹤0.01% 6009
2023
Q2 		– Sell
-561
Closed -$23.2K – 9687
2023
Q1 		$22K Sell
561
-110
-16% -$4.38K ﹤0.01% 6823
2022
Q4 		$25K Buy
+671
New +$32.6K ﹤0.01% 6660
2022
Q1 		– Sell
-1,041
Closed -$69.4K – 11141
2021
Q4 		$62K Buy
+1,041
New +$57.4K ﹤0.01% 6947
2020
Q2 		– Sell
-1,565
Closed -$65.4K – 8153
2020
Q1 		$52K Buy
+1,565
New +$65K ﹤0.01% 5083
2019
Q2 		– Sell
-14,006
Closed -$595K – 7598
2019
Q1 		$533K Sell
14,006
-19,173
-58% -$748K ﹤0.01% 2599
2018
Q4 		$1.43M Buy
33,179
+8,996
+37% +$420K ﹤0.01% 1337
2018
Q3 		$1.19M Buy
24,183
+22,709
+1,541% +$982K ﹤0.01% 1716
2018
Q2 		$47K Sell
1,474
-21,739
-94% -$751K ﹤0.01% 5124
2018
Q1 		$723K Buy
23,213
+8,475
+58% +$302K 0.03% 530
2017
Q4 		$672K Sell
14,738
-21,221
-59% -$841K 0.03% 561
2017
Q3 		$1.35M Buy
+35,959
New +$1.45M 0.06% 285
2017
Q1 		– Sell
-27,152
Closed -$1.17M – 6633
2016
Q4 		$877K Buy
27,152
+25,193
+1,286% +$841K 0.05% 304
2016
Q3 		$67K Sell
1,959
-6,697
-77% -$262K ﹤0.01% 1859
2016
Q2 		$291K Buy
8,656
+7,137
+470% +$351K 0.02% 790
2016
Q1 		$80K Sell
1,519
-5,285
-78% -$309K 0.01% 1544
2015
Q4 		$522K Buy
6,804
+6,625
+3,701% +$375K 0.04% 416
2015
Q3 		$7K Buy
+179
New +$11K ﹤0.01% 3754

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's PCRX Position: Q1 2026 in Review

Simplex Trading opened a new position in Pacira BioSciences (PCRX) in Q1 2026: 56 shares worth $1.26K. The stake represents ﹤0.01% of the portfolio and ranks #8520 among its holdings. This is a return to the name: Simplex Trading previously reported a position in PCRX as recently as Q2 2025.

Simplex Trading first reported a position in PCRX in Q3 2015 and has held it in 22 quarters since. The position peaked at $1.43M in Q4 2018. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

  • Simplex Trading held 56 shares of Pacira BioSciences worth $1.26K as of Q1 2026.
  • Pacira BioSciences was a new Simplex Trading position in Q1 2026.
  • Pacira BioSciences made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8520 holding.
  • Simplex Trading first reported a position in Pacira BioSciences in Q3 2015 and has held it in 22 quarters since.
  • Simplex Trading's Pacira BioSciences position peaked at $1.43M in Q4 2018.
  • 241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.